Optimizing machine learning-based diagnosis of neurosyphilis in HIV-negative patients: a multicenter, real-world comparison of international diagnostic criteria
Clinical Snapshot
PICO Framework
| P — Population | HIV-negative patients with suspected neurosyphilis from four international centers (Guangzhou, Beijing, Xiamen, Seattle) |
| I — Intervention | Machine learning diagnostic models based on six international diagnostic guidelines |
| C — Comparator | Traditional diagnostic approaches using international criteria without ML enhancement |
| O — Outcomes | Diagnostic accuracy metrics (AUC, PRAUC, sensitivity, specificity), calibration, clinical utility via decision curve analysis |
Bottom Line
This multicenter study developed machine learning models for neurosyphilis diagnosis in HIV-negative patients, achieving excellent discrimination (AUC >0.90) across six international diagnostic guidelines. The models consistently identified neurological symptoms, CSF protein, and CSF white blood cell count as key predictors. External validation across diverse geographic settings (China and USA) demonstrated robust performance with good calibration and positive clinical utility. The freely available web-based tool offers significant potential to improve diagnostic accuracy, particularly in resource-limited settings where specialist expertise and comprehensive CSF testing may be unavailable. However, the abstract lacks specific sensitivity/specificity values and confidence intervals, limiting full assessment of clinical utility. The approach addresses a critical diagnostic challenge in infectious diseases, though clinicians should await full publication details before implementation.
Key Findings
P Value: Not reported in abstract
Effect Size: AUC and PRAUC >0.90 for all models
Primary Outcome: Diagnostic accuracy across six international guidelines using machine learning models
Nnt Or Sensitivity: Sensitivity and specificity values not specified in abstract, though excellent discrimination (AUC >0.90) suggests high diagnostic accuracy
Confidence Interval: Not reported in abstract
Clinical Application
High feasibility with free web-based tool requiring only basic clinical and CSF parameters Highly relevant for Australian practice given rising neurosyphilis rates; tool could support rural and remote clinicians with limited access to specialist expertise; aligns with RACGP emphasis on evidence-based diagnostic support tools HIV-negative patients with suspected neurosyphilis in both resource-rich and resource-limited healthcare settings
Abstract
Neurosyphilis continues to rise globally, yet diagnosis remains challenging, often requiring multidisciplinary expertise and multiple CSF assays that are difficult to access in resource-limited settings. We developed and compared machine-learning (ML) models tailored to six international diagnostic guidelines and built a free, web-based tool for guideline-adapted decision support. We assembled 1,648 suspected neurosyphilis cases from four centers, using Guangzhou as the training cohort and Beijing, Xiamen (China) and Seattle (USA) as external validation cohorts. Five algorithms (Random Forest, AdaBoost, SVC, NuSVC, XGBoost) were trained with randomized search and three-fold cross-validation; performance was assessed by AUC, PRAUC, calibration, decision-curve net benefit, Brier score, and SHAP for model explainability. Across models and guidelines, neurological symptoms, CSF protein, and CSF white blood cell count consistently ranked as the strongest predictors. All models achieved excellent discrimination (AUC and PRAUC >0.90) with good calibration, reliability, and positive clinical utility, though performance varied modestly by guideline. These findings indicate that the optimal ML approach depends on the diagnostic definition applied. Our freely available online tool operationalizes these models to provide clinicians worldwide with context-adapted support aligned to local criteria.
Related Research
Journal of medical Internet research
Advancing Human-Centered AI in Clinical Decision Support: Sociocognitive Human-in-the-Loop Study in HIV Care
2 Aug 2026
JBJS reviews
One-Stage or Two-Stage Revision for Infected Shoulder Arthroplasty: A Head-to-Head Meta-Analysis of Comparative Studies
30 July 2026
Signal transduction and targeted therapy
Mucosal immunity and vaccine development
27 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service